Complete Omics Industrial Services

Accelerate clinical development with top-publication proven assays

Unmatched sensitivity and specificity for confident target detection. Interested in learning more about how Complete Omics can support your pre-clinical research and clinical trials?  

Get in touch

For Biopharma

Complete Omics leverages unmatched sensitivity and specificity for proteomics assays to accelerate pre-clinical research and clinical trials, and produce insights that drive biopharma pipeline development.
 

Click to enlarge

Quick View for Our Most Popular Service used by Biopharma

Valid-NEO® Neoantigen Assay

Complete Omics Valid-NEO® is a tumor-informed therapeutic target assay that begins with NGS data to identify sample-specific neoantigens. A personalized Valid-NEO® assay can be developed to detect personalized neoantigen therapeutic targets from cell lines, tissues, biopsy, or surgical resections from early to late stages of cancers .

valid-neo-process--web
 

Click to enlarge

HS-grid-items (2)
HS-grid-items (1)

 

Our Services for Biopharma

 
Complete360® - Sensitive and accurate biomarker panel detection

Complete360® is powered by Complete Omics' special chemistry to achieve sensitivity down to 1 part per million (1 PPM, or 0.0001% tumor fraction) with 100% specificity observed.

 

Click to enlarge

 
CompleteCohort® - Multi-Omics assays for Large Cohort Projects including hundreds to thousands of samples

CompleteCohort® delivers exceptional depth and reproducibility among all your samples. The assay's highly reproducible procedure allows the quantitative proteomics data to be comparable with not only within this study, but also outside databases, which dramatically expends and improves the impact of your data.

 

Click to enlarge

 

Click to enlarge

 
Valid-NEO® Neoantigen Identification and Quantification

Unlike other tests, Valid-NEO® was purpose-built for neoantigen validation that reports neoantigen sequences and their abundances. In addition to reporting sample-level immunopeptidome profiling result, Valid-NEO® can targetedly quantify specific neoantigens down to sub-copy level per cell, aiding immunogencity evaluation and providing therapeutic guidance.

 

Click to enlarge

Neoantigen-target-therapeutics
 

Click to enlarge

HS-grid-items (1)
middle-aged-man-pondering middle-aged-man-pondering-hover

Contact Us

Get in touch

With our deep roots in proteomics and multi-omics fields, Complete Omics is committed to providing biopharma solutions to improve clinical R&D. Let our unmatched clinical proteomics capabilities and team of global experts support your clinical research and therapeutic development efforts.

Have questions? We would love to hear from you. Simply click the button below.

Get in touch